Non-Invasive Cholesterol Reader Global Market Report 2025

The non-invasive cholesterol reader market size has grown rapidly in recent years. It will grow from $1.13 billion in 2024 to $1.3 billion in 2025 at a compound annual growth rate (CAGR) of 15.5%. Growth during the historic period can be attributed to the rising prevalence of cardiovascular diseases, increasing awareness of cholesterol monitoring, growing demand for preventive healthcare solutions, surge in government healthcare initiatives, expansion of healthcare infrastructure in emerging economies, and the increasing adoption of home-based health monitoring devices.

The non-invasive cholesterol reader market size is expected to see rapid growth in the next few years. It will grow to $2.29 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. Growth during the forecast period can be attributed to the increasing focus on early disease detection and management, rising geriatric population prone to lipid disorders, growing healthcare expenditure in both developed and developing countries, surge in lifestyle-related health issues, expansion of insurance coverage for diagnostic screenings, and increasing patient preference for non-invasive diagnostic solutions. Key trends expected during this period include technological progress in optical sensing techniques, advancements in wearable biosensor integration, innovations in point-of-care diagnostic platforms, developments in real-time cholesterol monitoring systems, research and development in non-invasive lipid profiling methods, and improvements in data analytics for personalized cholesterol management.

The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the non-invasive cholesterol reader market in the coming years. Cardiovascular diseases, including coronary artery disease, stroke, and heart failure, are becoming increasingly common due to aging populations and sedentary lifestyles that elevate the risk of heart and vascular complications. Non-invasive cholesterol readers play a crucial role in early detection by enabling quick cholesterol measurements without the need for blood samples, supporting timely interventions to reduce the risk of heart attacks and strokes. For example, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, cardiovascular diseases caused 919,032 deaths in 2023, accounting for nearly one-third of all deaths. Hence, the growing incidence of cardiovascular diseases is contributing significantly to the expansion of the non-invasive cholesterol reader market.

The rise in healthcare expenditure is expected to boost the growth of the non-invasive cholesterol reader market. Healthcare expenditure encompasses total spending on medical services, treatments, and health-related goods aimed at improving population health. The steady increase in healthcare spending is primarily driven by the growing burden of chronic diseases, which demand ongoing care and management. Higher investment in healthcare facilitates the development and adoption of non-invasive diagnostic technologies that enable early cholesterol monitoring and reduce dependence on invasive procedures and costly hospital visits. For instance, according to the Office for National Statistics (ONS), a U.K.-based government agency, public healthcare spending in the United Kingdom reached $346 billion (£258 billion) in 2024, marking a 2.5% increase in real terms compared to 2023. Therefore, the rising healthcare expenditure is playing a pivotal role in driving demand for non-invasive cholesterol readers.

In August 2024, the National University of Singapore (NUS) collaborated with the Agency for Science, Technology and Research (ASTAR) to develop a non-invasive sensor capable of detecting cholesterol and glucose levels through the skin. The partnership aims to design and commercialize a wearable hydrogel-based sensor for continuous, real-time, and non-invasive monitoring of biomarkers such as cholesterol and glucose on dry skin. This innovation is expected to enhance early disease detection, chronic disease management, and remote health monitoring. ASTAR, a Singapore-based public research agency focused on economic-driven innovation, is actively contributing to the advancement of non-invasive cholesterol reader technologies.

Major players in the non-invasive cholesterol reader market are Syntec Optics, Philips Healthcare, Hoya Corporation, Revvity Inc., Canon Medical Systems Corporation, Agency for Science, Technology and Research (A*STAR), Jenoptik AG, Leica Microsystems GmbH, MLOptic Corp., Perimeter Medical Imaging AI Inc., PreVu Inc., Hamamatsu Photonics K.K., SiPhox Health Inc., Binah.ai Ltd., Occuity Ltd., Modulim Inc., Meyer Instruments Inc., DermaSensor Inc., MediBioSense Health Care, Medphab, and Syrma Johari MedTech Limited.

North America was the largest region in the non-invasive cholesterol reader market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in non-invasive cholesterol reader report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The non-invasive cholesterol reader market research report is one of a series of new reports that provides non-invasive cholesterol reader market statistics, including non-invasive cholesterol reader industry global market size, regional shares, competitors with a non-invasive cholesterol reader market share, detailed non-invasive cholesterol reader market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive cholesterol reader industry. This non-invasive cholesterol reader market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A non-invasive cholesterol reader is a medical device or diagnostic tool used to measure cholesterol levels in the body without the need for blood samples or needles. These devices commonly utilize technologies such as optical sensors, spectroscopy, or electromagnetic waves to detect cholesterol through the skin or other external methods.

The primary product types of non-invasive cholesterol readers include wearable devices, handheld devices, and tabletop devices. Wearable devices are small, body-mounted instruments such as patches, bands, or wristbands that collect physiological data continuously or at regular intervals with minimal discomfort. These devices operate using technologies such as optical, ultrasound, electrical, and others. They are distributed through both online and offline channels and are used across various applications, including home care, hospitals and clinics, diagnostic centers, and other healthcare settings.

The countries covered in the non-invasive cholesterol reader market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-invasive cholesterol reader market consists of sales of non-invasive skin cholesterol detection system, stretchable hydrogel-based wearable sensor, and cholesterol monitor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.